Humanigen Inc (HGENQ)

[TheGreatSwami]

KaloBios Receives M&A Advisor 2017 Turnaround Award
http://ir.kalobios.com/press-releases/detail/97


BRISBANE, Calif., March 27, 2017 (GLOBE NEWSWIRE) -- KaloBios Pharmaceuticals, Inc. (OTC:KBIO), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare diseases, announced today that it has been named an M&A Advisor Turnaround Award winner for Chapter 11 Reorganization of the Year.

KaloBios received the award in the $10 million to $25 million company size category for its work to successfully emerge from Chapter 11 bankruptcy on June 30, 2016.

“This award highlights our ability to execute in challenging circumstances to reach our goals and ultimately transform KaloBios,” said Cameron Durrant, MD, KaloBios chairman and CEO. “We are grateful for the recognition of our very talented team’s efforts.”

The award was presented at M&A Advisor’s 11th Annual Distressed Investing Summit. For more information on the conference and the award, please visit: http://www.cvent.com/events/2017-distressed-investing-summit-featuring-11th-annual-turnaround-awards/event-summary-4a15eb768f714edd8170809430c0a745.aspx.